CollPlant Biotechnologies (CLGN) Competitors $3.41 -0.26 (-7.08%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends CLGN vs. BWAY, PDEX, NVRO, SRTS, ZJYL, TLSI, TELA, GUTS, FONR, and MGRMShould you be buying CollPlant Biotechnologies stock or one of its competitors? The main competitors of CollPlant Biotechnologies include BrainsWay (BWAY), Pro-Dex (PDEX), Nevro (NVRO), Sensus Healthcare (SRTS), Jin Medical International (ZJYL), TriSalus Life Sciences (TLSI), TELA Bio (TELA), Fractyl Health (GUTS), FONAR (FONR), and Monogram Orthopaedics (MGRM). These companies are all part of the "medical equipment" industry. CollPlant Biotechnologies vs. BrainsWay Pro-Dex Nevro Sensus Healthcare Jin Medical International TriSalus Life Sciences TELA Bio Fractyl Health FONAR Monogram Orthopaedics BrainsWay (NASDAQ:BWAY) and CollPlant Biotechnologies (NASDAQ:CLGN) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, media sentiment, community ranking, risk, institutional ownership, earnings and analyst recommendations. Is BWAY or CLGN more profitable? BrainsWay has a net margin of 3.88% compared to CollPlant Biotechnologies' net margin of -2,680.00%. BrainsWay's return on equity of 3.52% beat CollPlant Biotechnologies' return on equity.Company Net Margins Return on Equity Return on Assets BrainsWay3.88% 3.52% 2.26% CollPlant Biotechnologies -2,680.00%-77.05%-61.43% Does the MarketBeat Community prefer BWAY or CLGN? CollPlant Biotechnologies received 70 more outperform votes than BrainsWay when rated by MarketBeat users. However, 66.67% of users gave BrainsWay an outperform vote while only 59.48% of users gave CollPlant Biotechnologies an outperform vote. CompanyUnderperformOutperformBrainsWayOutperform Votes6866.67% Underperform Votes3433.33% CollPlant BiotechnologiesOutperform Votes13859.48% Underperform Votes9440.52% Which has preferable valuation and earnings, BWAY or CLGN? BrainsWay has higher revenue and earnings than CollPlant Biotechnologies. CollPlant Biotechnologies is trading at a lower price-to-earnings ratio than BrainsWay, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBrainsWay$38.63M4.50-$4.20M$0.1092.40CollPlant Biotechnologies$650K60.09-$7.02M-$1.54-2.21 Does the media refer more to BWAY or CLGN? In the previous week, BrainsWay had 1 more articles in the media than CollPlant Biotechnologies. MarketBeat recorded 1 mentions for BrainsWay and 0 mentions for CollPlant Biotechnologies. BrainsWay's average media sentiment score of 0.96 beat CollPlant Biotechnologies' score of 0.00 indicating that BrainsWay is being referred to more favorably in the media. Company Overall Sentiment BrainsWay Positive CollPlant Biotechnologies Neutral Do analysts recommend BWAY or CLGN? BrainsWay presently has a consensus target price of $13.17, indicating a potential upside of 42.50%. CollPlant Biotechnologies has a consensus target price of $12.50, indicating a potential upside of 266.57%. Given CollPlant Biotechnologies' stronger consensus rating and higher possible upside, analysts plainly believe CollPlant Biotechnologies is more favorable than BrainsWay.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BrainsWay 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00CollPlant Biotechnologies 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Do institutionals & insiders believe in BWAY or CLGN? 30.1% of BrainsWay shares are held by institutional investors. Comparatively, 21.7% of CollPlant Biotechnologies shares are held by institutional investors. 19.0% of BrainsWay shares are held by insiders. Comparatively, 9.6% of CollPlant Biotechnologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has more volatility and risk, BWAY or CLGN? BrainsWay has a beta of 1.23, indicating that its share price is 23% more volatile than the S&P 500. Comparatively, CollPlant Biotechnologies has a beta of 0.51, indicating that its share price is 49% less volatile than the S&P 500. SummaryBrainsWay beats CollPlant Biotechnologies on 14 of the 19 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now Get CollPlant Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for CLGN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CLGN vs. The Competition Export to ExcelMetricCollPlant BiotechnologiesSurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$42.10M$9.53B$5.13B$9.07BDividend YieldN/A1.38%5.08%4.23%P/E Ratio-2.2119.5689.5817.17Price / Sales60.0932.801,116.12116.95Price / CashN/A22.3742.8237.86Price / Book1.385.494.774.78Net Income-$7.02M$182.72M$120.15M$225.60M7 Day Performance-7.59%-4.48%-1.92%-1.23%1 Month Performance-18.03%-4.23%11.47%3.36%1 Year Performance-35.05%-12.17%30.54%16.60% CollPlant Biotechnologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CLGNCollPlant Biotechnologies2.7207 of 5 stars$3.41-7.1%$12.50+266.6%-35.3%$42.10M$650,000.00-2.2170Positive NewsBWAYBrainsWay3.9069 of 5 stars$9.55+1.4%$13.17+37.9%+40.9%$159.28M$38.63M95.20120PDEXPro-Dex2.0616 of 5 stars$48.80-1.3%$52.00+6.6%+181.2%$159.09M$53.84M32.10140NVRONevro2.1372 of 5 stars$4.22+3.7%$8.05+90.8%-82.0%$158.12M$425.17M-2.231,215Analyst ForecastSRTSSensus Healthcare3.9962 of 5 stars$8.11-0.6%$12.50+54.1%+186.3%$132.92M$24.41M14.3240Positive NewsZJYLJin Medical InternationalN/A$0.79+1.7%N/A-99.0%$122.67M$19.82M0.00245Gap DownTLSITriSalus Life Sciences4.0213 of 5 stars$4.00+2.3%$12.08+202.1%-50.5%$121.97M$26.89M-1.57106Analyst ForecastInsider TradeNews CoveragePositive NewsGap UpTELATELA Bio2.9938 of 5 stars$2.81+1.4%$9.25+229.2%-49.8%$110.69M$58.45M-1.64120GUTSFractyl Health0.8828 of 5 stars$2.10+2.9%$22.00+947.6%N/A$101.01M$120,000.00-0.17102FONRFONAR1.0075 of 5 stars$15.40-0.8%N/A-25.8%$97.45M$102.01M11.09480MGRMMonogram Orthopaedics3.2381 of 5 stars$2.76+3.8%$4.00+44.9%-24.1%$94.70M$364,999.00-5.6628Gap Down Related Companies and Tools Related Companies BrainsWay Competitors Pro-Dex Competitors Nevro Competitors Sensus Healthcare Competitors Jin Medical International Competitors TriSalus Life Sciences Competitors TELA Bio Competitors Fractyl Health Competitors FONAR Competitors Monogram Orthopaedics Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CLGN) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CollPlant Biotechnologies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share CollPlant Biotechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CLGN Stock Alerts